BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21300148)

  • 1. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.
    Lupachyk S; Shevalye H; Maksimchyk Y; Drel VR; Obrosova IG
    Free Radic Biol Med; 2011 May; 50(10):1400-9. PubMed ID: 21300148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.
    Drel VR; Lupachyk S; Shevalye H; Vareniuk I; Xu W; Zhang J; Delamere NA; Shahidullah M; Slusher B; Obrosova IG
    Endocrinology; 2010 Jun; 151(6):2547-55. PubMed ID: 20357221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
    Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
    Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
    Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats.
    Stevens MJ; Li F; Drel VR; Abatan OI; Kim H; Burnett D; Larkin D; Obrosova IG
    J Pharmacol Exp Ther; 2007 Jan; 320(1):458-64. PubMed ID: 17021258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.
    Obrosova IG; Drel VR; Pacher P; Ilnytska O; Wang ZQ; Stevens MJ; Yorek MA
    Diabetes; 2005 Dec; 54(12):3435-41. PubMed ID: 16306359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.
    Obrosova IG; Xu W; Lyzogubov VV; Ilnytska O; Mashtalir N; Vareniuk I; Pavlov IA; Zhang J; Slusher B; Drel VR
    Free Radic Biol Med; 2008 Mar; 44(6):972-81. PubMed ID: 17976390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
    Shevalye H; Stavniichuk R; Xu W; Zhang J; Lupachyk S; Maksimchyk Y; Drel VR; Floyd EZ; Slusher B; Obrosova IG
    Biochem Pharmacol; 2010 Apr; 79(7):1007-14. PubMed ID: 19945439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
    Obrosova IG; Li F; Abatan OI; Forsell MA; Komjáti K; Pacher P; Szabó C; Stevens MJ
    Diabetes; 2004 Mar; 53(3):711-20. PubMed ID: 14988256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
    Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
    Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy.
    Li F; Drel VR; Szabó C; Stevens MJ; Obrosova IG
    Diabetes; 2005 May; 54(5):1514-22. PubMed ID: 15855340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
    Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
    Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion.
    Terashima T; Kojima H; Chan L
    FASEB J; 2012 Jan; 26(1):295-308. PubMed ID: 21978940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.
    Drel VR; Pacher P; Stavniichuk R; Xu W; Zhang J; Kuchmerovska TM; Slusher B; Obrosova IG
    Int J Mol Med; 2011 Oct; 28(4):629-35. PubMed ID: 21617845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy.
    Mohammad G; Siddiquei MM; Abu El-Asrar AM
    Mediators Inflamm; 2013; 2013():510451. PubMed ID: 24347828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
    Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
    Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
    Vareniuk I; Pavlov IA; Obrosova IG
    Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc supplementation alleviates diabetic peripheral neuropathy by inhibiting oxidative stress and upregulating metallothionein in peripheral nerves of diabetic rats.
    Liu F; Ma F; Kong G; Wu K; Deng Z; Wang H
    Biol Trace Elem Res; 2014 May; 158(2):211-8. PubMed ID: 24615552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.